Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOSUTINIB for Prostate cancer: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 5 adverse event reports in the FDA FAERS database where BOSUTINIB was used for Prostate cancer.

Most Reported Side Effects for BOSUTINIB

Side Effect Reports % Deaths Hosp.
Diarrhoea 1,820 23.4% 76 324
Nausea 886 11.4% 31 165
Fatigue 626 8.1% 33 136
Vomiting 469 6.0% 27 122
Death 465 6.0% 459 62
Rash 426 5.5% 7 70
Pleural effusion 398 5.1% 20 160
Neoplasm progression 376 4.8% 34 44
Dyspnoea 319 4.1% 20 133
Headache 283 3.6% 8 55
Drug intolerance 277 3.6% 6 24
Malaise 272 3.5% 12 68
Off label use 265 3.4% 13 46
Abdominal pain 234 3.0% 12 67
Arthralgia 218 2.8% 5 47

Other Indications for BOSUTINIB

Chronic myeloid leukaemia (4,231) Product used for unknown indication (350) Leukaemia (191) Philadelphia positive chronic myeloid leukaemia (101) Acute lymphocytic leukaemia (89) Myeloid leukaemia (83) Neoplasm malignant (59) Chronic myeloid leukaemia (in remission) (56) Philadelphia chromosome positive (53) Acute myeloid leukaemia (50)

Other Drugs Used for Prostate cancer

LEUPROLIDE (45,399) ENZALUTAMIDE (25,954) RELUGOLIX (18,752) ABIRATERONE (12,209) APALUTAMIDE (3,286) GOSERELIN (2,080) DEGARELIX (2,035) BICALUTAMIDE (1,832) SIPULEUCEL-T (1,720) DENOSUMAB (1,627)

Related Pages

BOSUTINIB Full Profile All Prostate cancer Drugs BOSUTINIB Demographics BOSUTINIB Timeline